Share your research articles, interpretations and experiences here. Let us know how these studies affect you and your decisions.
Posted on: Jun 1, 2018 06:33PM - edited Jun 2, 2018 02:00PM by Moderators
The CONTESSA study is looking to see if tesetaxel, an experimental taxane chemotherapy medicine that is taken orally as a pill, in combination with a lower-than-usual dose of Xeloda (chemical name: capecitabine) is better than the standard dose of Xeloda alone. Xeloda also is taken orally as a pill.
The CONTESSA study is being conducted at multiple sites around the world, including in the United States, the United Kingdom, Australia, France, Germany, Italy, Spain, and Russia.
For more information or to enroll, visit the CONTESSA Trial page on Breastcancer.org:http://www.breastcancer.org/treatment/clinical_trials/featured/contessa.
People are eligible to participate in the CONTESSA trial if they: